Buy Sanofi India: target of Rs 9249: Sharekhan
Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9249 in its research report dated February 23, 2021.
February 24, 2021 / 02:48 PM IST
Sharekhan's research report on Sanofi India
Sanofi India (Sanofi) reported a weak performance for the quarter with results missing estimates, though numbers are not comparable with previous quarters. Strong performance of top 10 brands which have dominant share in their respective segments augurs well and provides visibility on growth ahead. Sanofi has recommended dividend per share of Rs. 365 for CY2020, which translates into healthy dividend yield of ~4.5%. Better growth prospects, strong balance sheet with no debt, minimal capex, and healthy cash position are the key positives.
We retain Buy with an unchanged PT of Rs. 9,249.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.